179 related articles for article (PubMed ID: 34249818)
41. A human immunodeficiency caused by mutations in the PIK3R1 gene.
Deau MC; Heurtier L; Frange P; Suarez F; Bole-Feysot C; Nitschke P; Cavazzana M; Picard C; Durandy A; Fischer A; Kracker S
J Clin Invest; 2014 Sep; 124(9):3923-8. PubMed ID: 25133428
[TBL] [Abstract][Full Text] [Related]
42. Resolving the polygenic aetiology of a late onset combined immune deficiency caused by NFKB1 haploinsufficiency and modified by PIK3R1 and TNFRSF13B variants.
Hargreaves CE; Dhalla F; Patel AM; de Oteyza ACG; Bateman E; Miller J; Anzilotti C; Ayers L; Grimbacher B; Patel SY
Clin Immunol; 2022 Jan; 234():108910. PubMed ID: 34922003
[TBL] [Abstract][Full Text] [Related]
43. Differential signaling by regulatory subunits of phosphoinositide-3-kinase influences cell survival in INS-1E insulinoma cells.
Schrader J; Niebel P; Rossi A; Archontidou-Aprin E; Hörsch D
Exp Clin Endocrinol Diabetes; 2015 Feb; 123(2):118-25. PubMed ID: 25393342
[TBL] [Abstract][Full Text] [Related]
44. Individuals with Smith-Magenis syndrome display profound neurodevelopmental behavioral deficiencies and exhibit food-related behaviors equivalent to Prader-Willi syndrome.
Alaimo JT; Barton LV; Mullegama SV; Wills RD; Foster RH; Elsea SH
Res Dev Disabil; 2015 Dec; 47():27-38. PubMed ID: 26323055
[TBL] [Abstract][Full Text] [Related]
45. PIK3R1 mutations cause syndromic insulin resistance with lipoatrophy.
Thauvin-Robinet C; Auclair M; Duplomb L; Caron-Debarle M; Avila M; St-Onge J; Le Merrer M; Le Luyer B; Héron D; Mathieu-Dramard M; Bitoun P; Petit JM; Odent S; Amiel J; Picot D; Carmignac V; Thevenon J; Callier P; Laville M; Reznik Y; Fagour C; Nunes ML; Capeau J; Lascols O; Huet F; Faivre L; Vigouroux C; Rivière JB
Am J Hum Genet; 2013 Jul; 93(1):141-9. PubMed ID: 23810378
[TBL] [Abstract][Full Text] [Related]
46. Autoimmune Cytopenia as an Early and Initial Presenting Manifestation in Activated PI3 Kinase Delta Syndrome: Case Report and Review.
Schworer SA; Francis OL; Johnson SM; Smith BD; Gold SH; Smitherman AB; Wu EY
J Pediatr Hematol Oncol; 2021 Nov; 43(8):281-287. PubMed ID: 34054047
[TBL] [Abstract][Full Text] [Related]
47. Divergent roles of the regulatory subunits of class IA PI3K.
Kim CW; Lee JM; Park SW
Front Endocrinol (Lausanne); 2023; 14():1152579. PubMed ID: 38317714
[TBL] [Abstract][Full Text] [Related]
48. Activated phosphoinositide 3-kinase delta syndrome 1 and 2 (APDS 1 and APDS 2): similarities and differences based on clinical presentation in two boys.
Ewertowska M; Grześk E; Urbańczyk A; Dąbrowska A; Bąbol-Pokora K; Łęcka M; Kołtan S
Allergy Asthma Clin Immunol; 2020; 16():22. PubMed ID: 32265996
[TBL] [Abstract][Full Text] [Related]
49. Smith-Magenis Syndrome Patients Often Display Antibody Deficiency but Not Other Immune Pathologies.
Perkins T; Rosenberg JM; Le Coz C; Alaimo JT; Trofa M; Mullegama SV; Antaya RJ; Jyonouchi S; Elsea SH; Utz PJ; Meffre E; Romberg N
J Allergy Clin Immunol Pract; 2017; 5(5):1344-1350.e3. PubMed ID: 28286158
[TBL] [Abstract][Full Text] [Related]
50. Altered signaling and cell cycle regulation in embryonal stem cells with a disruption of the gene for phosphoinositide 3-kinase regulatory subunit p85alpha.
Hallmann D; Trümper K; Trusheim H; Ueki K; Kahn CR; Cantley LC; Fruman DA; Hörsch D
J Biol Chem; 2003 Feb; 278(7):5099-108. PubMed ID: 12435753
[TBL] [Abstract][Full Text] [Related]
51. Diagnostic evaluation of paediatric autoimmune lymphoproliferative immunodeficiencies (ALPID): a prospective cohort study.
Hägele P; Staus P; Scheible R; Uhlmann A; Heeg M; Klemann C; Maccari ME; Ritterbusch H; Armstrong M; Cutcutache I; Elliott KS; von Bernuth H; Leahy TR; Leyh J; Holzinger D; Lehmberg K; Svec P; Masjosthusmann K; Hambleton S; Jakob M; Sparber-Sauer M; Kager L; Puzik A; Wolkewitz M; Lorenz MR; Schwarz K; Speckmann C; Rensing-Ehl A; Ehl S;
Lancet Haematol; 2024 Feb; 11(2):e114-e126. PubMed ID: 38302222
[TBL] [Abstract][Full Text] [Related]
52. Immunodeficiency due to a novel variant in PIK3CD: a case report.
Shashaani N; Chavoshzadeh Z; Ghasemi L; Ghotbabadi SH; Shiari S; Sharafian S; Shiari R
Pediatr Rheumatol Online J; 2023 Jul; 21(1):71. PubMed ID: 37475052
[TBL] [Abstract][Full Text] [Related]
53. Methylphenidate for attention-deficit/hyperactivity disorder in patients with Smith-Magenis syndrome: protocol for a series of N-of-1 trials.
Müller AR; Zinkstok JR; Rommelse NNJ; van de Ven PM; Roes KCB; Wijburg FA; de Rooij-Askes E; Linders C; Boot E; van Eeghen AM
Orphanet J Rare Dis; 2021 Sep; 16(1):380. PubMed ID: 34496899
[TBL] [Abstract][Full Text] [Related]
54. Smith-Magenis syndrome: Clinical and behavioral characteristics in a large retrospective cohort.
Rive Le Gouard N; Jacquinet A; Ruaud L; Deleersnyder H; Ageorges F; Gallard J; Lacombe D; Odent S; Mikaty M; Manouvrier-Hanu S; Ghoumid J; Geneviève D; Lehman N; Philip N; Edery P; Héron D; Rastel C; Chancenotte S; Thauvin-Robinet C; Faivre L; Perrin L; Verloes A
Clin Genet; 2021 Apr; 99(4):519-528. PubMed ID: 33368193
[TBL] [Abstract][Full Text] [Related]
55. Reciprocal deletion and duplication of 17p11.2-11.2: Korean patients with Smith-Magenis syndrome and Potocki-Lupski syndrome.
Lee CG; Park SJ; Yun JN; Yim SY; Sohn YB
J Korean Med Sci; 2012 Dec; 27(12):1586-90. PubMed ID: 23255863
[TBL] [Abstract][Full Text] [Related]
56. Cerebral Venous Thrombosis in a Patient With Smith-Magenis Syndrome.
Zahoor H; Hamza A; Aigbe E; Vather-Wu D; Guzman N
Cureus; 2023 Mar; 15(3):e36858. PubMed ID: 37123798
[TBL] [Abstract][Full Text] [Related]
57. Insulin resistance uncoupled from dyslipidemia due to C-terminal PIK3R1 mutations.
Huang-Doran I; Tomlinson P; Payne F; Gast A; Sleigh A; Bottomley W; Harris J; Daly A; Rocha N; Rudge S; Clark J; Kwok A; Romeo S; McCann E; Müksch B; Dattani M; Zucchini S; Wakelam M; Foukas LC; Savage DB; Murphy R; O'Rahilly S; Barroso I; Semple RK
JCI Insight; 2016 Oct; 1(17):e88766. PubMed ID: 27766312
[TBL] [Abstract][Full Text] [Related]
58. Activated phosphoinositide 3-dinase delta syndrome (APDS): An update.
Lougaris V; Cancrini C; Rivalta B; Castagnoli R; Giardino G; Volpi S; Leonardi L; La Torre F; Federici S; Corrente S; Cinicola BL; Soresina A; Marseglia GL; Cardinale F
Pediatr Allergy Immunol; 2022 Jan; 33 Suppl 27(Suppl 27):69-72. PubMed ID: 35080319
[TBL] [Abstract][Full Text] [Related]
59. Calorie Restriction-Induced Increase in Skeletal Muscle Insulin Sensitivity Is Not Prevented by Overexpression of the p55α Subunit of Phosphoinositide 3-Kinase.
Martins VF; Tahvilian S; Kang JH; Svensson K; Hetrick B; Chick WS; Schenk S; McCurdy CE
Front Physiol; 2018; 9():789. PubMed ID: 29997524
[No Abstract] [Full Text] [Related]
60. p85alpha gene generates three isoforms of regulatory subunit for phosphatidylinositol 3-kinase (PI 3-Kinase), p50alpha, p55alpha, and p85alpha, with different PI 3-kinase activity elevating responses to insulin.
Inukai K; Funaki M; Ogihara T; Katagiri H; Kanda A; Anai M; Fukushima Y; Hosaka T; Suzuki M; Shin BC; Takata K; Yazaki Y; Kikuchi M; Oka Y; Asano T
J Biol Chem; 1997 Mar; 272(12):7873-82. PubMed ID: 9065454
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
